John P. Butler

CEO and President at Akebia Therapeutics Inc.

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
4 years
Director since
2023

4 years of board service in total across 1 board, counting each seat separately. Longest: Akebia Therapeutics Inc., 3 years.

Akebia Therapeutics Inc. Director · CEO and President
3 years · Since 2023

Chief executive roles

Akebia Therapeutics Inc. · CEO and President
Dates unknown

Shareholder support

Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Aug 6, 2026 Akebia Therapeutics Inc. Option exercise +350,000 $0.63 $220,500
Mar 4, 2026 Akebia Therapeutics Inc. Open-market purchase +69,270 $1.25 $86,588
Feb 2, 2026 Akebia Therapeutics Inc. Open-market sale −46,660 $1.39 $64,857
Feb 2, 2026 Akebia Therapeutics Inc. Open-market sale −96,065 $1.39 $133,530
Feb 2, 2026 Akebia Therapeutics Inc. Open-market sale −114,891 $1.39 $159,698
Feb 2, 2026 Akebia Therapeutics Inc. Grant or award +175,250 $1.41 $247,103
Feb 2, 2026 Akebia Therapeutics Inc. Open-market sale −83,689 $1.39 $116,328
Jan 30, 2026 Akebia Therapeutics Inc. Grant or award +743,000 — —
Mar 3, 2025 Akebia Therapeutics Inc. Open-market sale −46,409 $1.83 $84,928
Feb 3, 2025 Akebia Therapeutics Inc. Open-market sale −46,268 $2.10 $97,163
Feb 3, 2025 Akebia Therapeutics Inc. Open-market sale −97,982 $2.10 $205,762
Jan 31, 2025 Akebia Therapeutics Inc. Grant or award +701,000 — —
Feb 29, 2024 Akebia Therapeutics Inc. Open-market sale −46,570 $1.58 $73,581
Feb 27, 2024 Akebia Therapeutics Inc. Open-market sale −37,733 $1.52 $57,354
Feb 1, 2024 Akebia Therapeutics Inc. Open-market sale −46,489 $1.68 $78,102

Questions about John P. Butler

What boards is John P. Butler on?

John P. Butler sits on the board of Akebia Therapeutics Inc.

What company is John P. Butler the CEO of?

John P. Butler is CEO and President of Akebia Therapeutics Inc.

How long has John P. Butler served on boards?

Our records show at least 4 years of board service across 1 board, the earliest from 2023.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.